Floatz logo

Cytokine Induced Memory-Like Natural Killer Cells

Renal Carcinoma

Dana-Farber Cancer InstituteCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
89/ 100

Competitive context

41 Active assets in the Renal Carcinoma cohort.

Asset / SponsorPhaseRating
Nivolumab
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4BBB
Bms-907351
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4BB
Ipilimumab
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4BB
Pembrolizumab
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4BB
Arestin
RenJi Hospital
Phase 3B

View all 50 →

Same molecule, other indications

Cytokine Induced Memory-Like Natural Killer Cells is also rated in:

Myeloproliferative DisordersDormant
CC
Indicative ·
43 / 100
View asset →
myeloid leukemiaDormant
CC
Indicative ·
41 / 100
View asset →
myeloproliferative neoplasmDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →